Review article: role of proton pump inhibitors in non-H. pylori-related ulcers (Q34369614)

1 August 2017

1 reference

title

Review article: role of proton pump inhibitors in non-H. pylori-related ulcers (English)

1 reference

1 August 2017

1 reference

Freston JW

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Alimentary Pharmacology & Therapeutics

1 August 2017

published in

1 reference

1 August 2017

volume

15 Suppl 2

1 reference

1 August 2017

page(s)

2-5

1 reference

Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

Helicobacter pylori eradication in patients with non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

Prevention of duodenal ulcer recurrence with 15 mg lansoprazole: a double-blind placebo-controlled study. The Lansoprazole Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00114.X

10.1046/J.1365-2036.2001.00114.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference